Search

Search Constraints

You searched for: Author/Creator Lobo, Beatriz

Search Results

1. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Issue 8 (25th May 2012)

2. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study. Issue 6 (October 2017)

3. Downregulation of mucosal mast cell activation and immune response in diarrhoea‐irritable bowel syndrome by oral disodium cromoglycate: A pilot study. Issue 6 (1st October 2017)

4. Effect of selective CCK1 receptor antagonism on accommodation and tolerance of intestinal gas in functional gut disorders. Issue 2 (28th January 2016)

5. Emergence of linezolid-resistant coagulase-negative staphylococci in an intensive care unit. Issue 5 (3rd May 2016)

6. Increased antibody response in the intestinal mucosa of diarrhoea-prone irritable bowel syndrome in association with psychological stress and abdominal pain. (November 2015)

7. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations. Issue 9 (10th September 2014)

8. MiR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea. Issue 9 (12th January 2017)

9. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. (27th December 2020)

10. Post COVID-19 irritable bowel syndrome. Issue 3 (9th December 2022)